Product Specifications

  • Solas8® device and MatMaCorp COVID-19 2SF Test
  • Nasopharyngeal (NP) swabs in transport media
  • Two-step RT-PCR based assay
  • Synthetic positive control RNA included in each run of samples
  • LoD is 100 copies per reaction
  • Designed for high-complexity CLIA labs
  • Total device run time is about two hours

Questions? Call customer support at 402-387-7900.

BUY NOW

Product Specifications

  • Solas8® device and MatMaCorp COVID-19 2SF Test
  • Nasopharyngeal (NP) swabs in transport media
  • Two-step RT-PCR based assay
  • Synthetic positive control RNA included in each run of samples
  • LoD is 100 copies per reaction
  • Designed for high-complexity CLIA labs
  • Total device run time is about two hours

Questions? Call customer support at 402-387-7900.

BUY NOW

Helpful Links

Order & Fulfillment

  • Place your order by filling out the order form.
  • Your CLIA certification number is required.
  • Cassling will review your order to ensure it meets the EUA requirements. We reserve the right to reject any order that does not comply.
  • Within 24 hours, you’ll receive an order confirmation via email.
  • Product arrives within two days, delivered by FedEx.
  • An invoice will be sent by the manufacturer after your product has arrived.
  • Payment is due within 30 days.

Order & Fulfillment

  • Place your order by filling out the order form.
  • Your CLIA certification number is required.
  • Cassling will review your order to ensure it meets the EUA requirements. We reserve the right to reject any order that does not comply.
  • Within 24 hours, you’ll receive an order confirmation via email.
  • Product arrives within two days, delivered by FedEx.
  • An invoice will be sent by the manufacturer after your product has arrived.
  • Payment is due within 30 days.

Training & Implementation

  • Training is conducted on site at your facility (masks required). The manufacturer will contact you directly to schedule. It lasts about 4 hours. There is no cost.
  • Here’s what you need to begin:
    • Ethernet cable or WiFi (for results to be accessible on your network)
    • Adjustable volume pipettors (2-20 ul, 20-200 ul, and 100-1000 ul ranges)
    • Barrier (filter) tips for each pipettor
    • Sterile, lab-grade water to hydrate reagents (~0.5 mL needed per run)
    • Biosafety cabinet or suitable barrier for handling specimens
    • Upper respiratory (NP, MT or AN) swabs in Copan UTM/VTM or equivalent
  • Customer support is available 8AM-5PM at 402-387-7900.
  • Coming soon! Online training will be available in Spring 2021.

Training & Implementation

  • Training is conducted on site at your facility (masks required). The manufacturer will contact you directly to schedule. It lasts about 4 hours. There is no cost.
  • Here’s what you need to begin:
    • Ethernet cable or WiFi (for results to be accessible on your network)
    • Adjustable volume pipettors (2-20 ul, 20-200 ul, and 100-1000 ul ranges)
    • Barrier (filter) tips for each pipettor
    • Sterile, lab-grade water to hydrate reagents (~0.5 mL needed per run)
    • Biosafety cabinet or suitable barrier for handling specimens
    • Upper respiratory (NP, MT or AN) swabs in Copan UTM/VTM or equivalent
  • Customer support is available 8AM-5PM at 402-387-7900.
  • Coming soon! Online training will be available in Spring 2021.

Order the Solas8® Today

Click the button below to be taken to our order form, then simply select the number of devices and testing kits you'd like to order.

BUY NOW

solas8-1

Disclaimer: This test has not been FDA cleared or approved but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories; This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and The emergency use of this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.